This page shows the latest Strides Arcolab news and features for those working in and with pharma, biotech and healthcare.
Cipla, Cadila Healthcare, Hetero, Strides Arcolab, Ranbaxy, Sequent Scientific and Mylan) at a 7% royalty rate.
Strides Arcolab - include some of the world's largest generic players, reports the Pharmalot blog.
Last year, generics giant Mylan made a big leap forward in the sector with a $1.6bn agreement to buy Strides Arcolab's sterile injectables unit Agila, while Becton Dickinson has
Hikma said in March it decided to look into the future of the division after being sent unsolicited offers in the wake of Mylan's $1.6bn deal to acquire Strides ... Arcolab's injectables unit.
Hikma has said it is looking into the future of its injectable drugs unit after overtures from possible buyers, just days after Mylan agreed a $1.6bn deal to buy Strides ... Mylan said when it announced its deal for Strides Arcolab's Agila unit that it
Generics firm becomes “top three player” in injectables. Consolidation continues apace in the generics sector, with Mylan agreeing a $1.6bn deal to acquire Strides Arcolab of India's sterile injectables
More from news
Approximately 1 fully matching, plus 10 partially matching documents found.
360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
200. Shasun / Strides Arcolab. Company acquisition. Shasun is an Indian API and generic company.
year. In India this month, Strides Arcolab has acquired another Indian generic and API supplier Shasun in an all stock deal worth $200m to add products to its portfolio.
with Strides Arcolab to jointly manufacture and distribute generic cancer drugs in developing markets.
Geographic expansion and consolidation. Mylan, the generics giant, has announced a trio of deals with Indian companies this month. In the largest, it announced its planned acquisition of Strides Arcolab's
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
No results were found
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...